To verify the biological function of the TGFβ-SMAD2 axis in the neuron-tumor coculture system, we took the advantage of a small-molecule inhibitor of TGFβ receptor type I (TGFβRI) kinase galunisertib to inhibit the TGFβ signaling in tumor cells. Here, TGFB1 is linked to neoplasm.